Detailed view for OVOC3515
Basic information
Onchocerca volvulus, Cyclin-H homolog
Source Database / ID: Wormbase Parasite
pI: 8.1174 |
Length (AA): 1251 |
MW (Da): 140066 |
Paralog Number:
8169
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Network
Pfam domains
Gene Ontology
Metabolic Pathways
Structural information
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
| Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 154 | 1jkw (A) | 97 | 249 | 26.00 | 0.000000078 | 0.49 | 1.2317 | 0.63 |
| 1 | 120 | 1jkw (A) | 97 | 217 | 34.00 | 0.000000000021 | 0.98 | 1.14002 | 0.47 |
Help me make sense of these data.
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Expression
Orthologs
Essentiality
Phenotypes and Validation (curated)
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Annotated validation
Associated compounds / Druggability
Known modulators for this target
Predicted associations
By orthology with druggable targets
By sequence similarity to non orthologous druggable targets
| Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
|---|---|---|---|---|---|---|
| Rattus norvegicus | Tyrosine-protein kinase Lyn | 512 aa | 42.1% | 461 aa | Compounds | References |
| Rattus norvegicus | Jak1 protein | 210 aa | 37.5% | 200 aa | Compounds | References |
| Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 31.6% | 155 aa | Compounds | References |
| Gallus gallus | Tyrosine-protein kinase SRC | 533 aa | 44.8% | 453 aa | Compounds | References |
| Rattus norvegicus | Tyrosine-protein kinase FGR | 517 aa | 42.7% | 461 aa | Compounds | References |
| Rattus norvegicus | Tyrosine-protein kinase SRC | 536 aa | 45.0% | 451 aa | Compounds | References |
| Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 23.0% | 296 aa | Compounds | References |
Obtained from network model
Assayability
Assay information
Reagent availability
Bibliographic References